πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381744

Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381405

Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378277

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378276

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378257

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378097

Use of penetration enhancers and barrier disruption methods to enhance the immune response

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378093

Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375185

Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375079

Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374931

Vaccine against staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374872

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374756

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371572

Mouse titers after two immunizations with VLPs alone

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371392

Cd40 ligand adjuvant for respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371385

Method of treating immune pathologies with low dose estrogen

Government of the United states of America dba The Department of Veterans Affairs Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371225

Method for convection enhanced delivery of therapeutic agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368114

Fusion protein including of CD4

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368110

Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and me

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7364719

Vasoregulating compounds and methods of their use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted